J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM)

NSE:JBCHEPHARM Revenue

In the fiscal year ending March 31, 2026, J. B. Chemicals & Pharmaceuticals had annual revenue of 41.48B INR with 5.87% growth. J. B. Chemicals & Pharmaceuticals had revenue of 9.04B in the quarter ending March 31, 2026, a decrease of -4.77%.

• Revenue: 41.48B
• Revenue Growth: +5.87%
• P/S Ratio: 8.41
• Revenue / Employee: 7.40M
• Employees: 5,602
• Market Cap: 348.75B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	41.48B	2.30B	5.87%
Mar 31, 2025	39.18B	4.34B	12.45%
Mar 31, 2024	34.84B	3.35B	10.63%
Mar 31, 2023	31.49B	7.25B	29.91%
Mar 31, 2022	24.24B	3.82B	18.69%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 6, 2026

Data Sources Report a data error